We propose that loss of BMP2 leads to deregulation in multiple signaling pathways involving cell cycle, DNA replication, and DNA damage response resulting in CRC development, progression and possibly resistance to chemotherapy. This evidence concerns the gene BMP2 and colorectal carcinoma.